Changes and prognostic values of tumor-infiltrating lymphocyte subsets after primary systemic therapy in breast cancer. Ahn S, Chung YR, Seo AN, Kim M, et al. PLoS One 2020;15:e0233037.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ahn S, Chung YR, Seo AN, Kim M, et al. Changes and prognostic values of tumor-infiltrating lymphocyte subsets after primary systemic therapy in breast cancer. PLoS One 2020;15:e0233037.
PMID: 32401825